Efficacy Study of Helicobacter Pylori Eradication in Patients Undergoing Subtotal Gastrectomy for Gastric Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

190

Participants

Timeline

Start Date

July 31, 2003

Primary Completion Date

March 31, 2006

Study Completion Date

March 31, 2009

Conditions
Gastric Cancer
Interventions
DRUG

Helicobacter pylori eradication

Omeprazole 20 mg or Rabeprazole 10 mg bid + clarithromycin 500 mg and amoxicillin 1,000 mg bid for 7 days

DRUG

placebo

Omeprazole 20 mg or Rabeprazole 10 mg bid + two placebo (for antibiotics) for 7 days

Trial Locations (1)

410-769

Research Institute and Hospital, National Cancer Center, Goyang-si

All Listed Sponsors
lead

National Cancer Center, Korea

OTHER_GOV

NCT01002443 - Efficacy Study of Helicobacter Pylori Eradication in Patients Undergoing Subtotal Gastrectomy for Gastric Cancer | Biotech Hunter | Biotech Hunter